← FDA Drug Approvals (Drugs@FDA)

TERBUTALINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2008-01-07

Drug application

FDA Application #
ANDA078151
Application type
Abbreviated New Drug Application (Generic)
Brand name
TERBUTALINE SULFATE
Generic name
Terbutaline Sulfate
Active ingredients
TERBUTALINE SULFATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
EPIC PHARMA LLC
First approval
2008-01-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown